泌尿病中的乳酸修饰:分子机制和生物学影响
Songyuan Yang1, Zehua Ye1, Sheng Zhao1
1Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Clinical epigenetics
|August 7, 2025
概括
乳糖化是一种乳酸的修饰,通过影响炎症和纤维化,影响泌尿病. 向乳化提供了预防和治疗脏,膀和尿道疾病的新策略.
科学领域:
- 生物化学 生物化学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 分子生物学分子生物学
背景情况:
- 泌尿系统疾病影响脏,尿道,膀和尿道,包括感染,结石和恶性瘤.
- 不同的病因需要针对泌尿病的预防和治疗策略.
研究的目的:
- 审查乳化在泌尿病中的生物功能和机械作用.
- 为了探索乳化对疾病发病和进展的影响.
- 突出乳糖调节的治疗和预防潜力.
主要方法:
- 关于乳化最近研究的文献综述.
- 分析乳化在关键生物过程中的作用 (炎症,血管新生,脂质代谢,纤维化).
主要成果:
- 乳化是一种翻译后的修饰,由乳酸的积累引起.
- 乳化会影响基因转录和蛋白质功能.
- 乳化对泌尿器疾病的发展有显著的贡献.
结论:
- 精确调节乳糖分是预后评估和尿道疾病治疗干预的有希望的途径.
- 了解乳化作用可以促进科学研究和泌尿病学临床实践.
相关概念视频
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Urinary Tract Infection II: Pathophysiology
44
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
44
Protein Modifications in the RER
5.6K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.6K
Covalently Linked Protein Regulators
7.2K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.2K
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
40
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
40
Inflammatory Bowel Disease IV: Pharmacological Management
190
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
190


